[Metabolic alterations, AIDS and vascular disease].
Betancor León
P
P
D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D050197:Atherosclerosis / Q000453:epidemiology; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000517:prevention & control; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000097:blood / Q000150:complications / Q000188:drug therapy / Q000378:metabolism*; D039682:HIV-Associated Lipodystrophy Syndrome / Q000453:epidemiology; D006801:Humans; D008055:Lipids / Q000097:blood; D024821:Metabolic Syndrome / Q000453:epidemiology*; D015995:Prevalence; D012307:Risk Factors; D012737:Sex Factors; D013997:Time Factors
D044966:Anti-Retroviral Agents; D008055:Lipids